Quantum study offers new insights into lithium’s effects in the brain
A new clue to how lithium may affect the brain has been found in new research into quantum biology at the University of Surrey. The study investigates how a quantum property of lithium atoms could influence chemical reactions involving vitamin C in the brain.
While lithium has been used as a first-line treatment for the long-term management of bipolar disorder for more than 70 years, scientists still do not fully understand how it produces its therapeutic effects in the brain.
In a new study published in PLOS One, Surrey researchers used computational chemistry and quantum simulations to investigate whether part of the answer could lie in ‘nuclear spin’ – a quantum property that makes an atom’s nucleus behave like a tiny magnet, allowing it to influence nearby electrons and potentially change the outcome of chemical reactions.
The study focused on the two stable isotopes of lithium – lithium-6 and lithium-7. Although chemically almost identical, their atomic nuclei have different quantum spins, and previous in vivo studies have found that this means they can produce different biological effects, including differences in their ability to reduce hyperactivity in rats.
The team modelled whether this difference could influence a chemical reaction involving flavin, a vitamin B2-derived molecule that helps proteins transfer electrons, and a radical derived from vitamin C (a form of the molecule with an unpaired electron). Vitamin C is abundant in brain cells called neurons and helps protect the brain against oxidative stress, while its radical can retain its spin state for relatively long periods, giving quantum effects more time to potentially influence the reaction.
Simulations showed that lithium-6 and lithium-7 could affect the reaction differently because of their different nuclear spins. The size of the predicted isotope effect was similar to that derived from previous animal studies comparing the behavioural effects of lithium-6 and lithium-7.
What fascinated us was the possibility that two almost chemically identical forms of lithium could influence biology differently because of a quantum property of their nuclei.Amina Mouhamed, PhD researcher at the University of Surrey and first author of the study
“If this difference could affect chemical reactions and ultimately contribute to changes in behaviour, it would demonstrate a remarkable link across scales, from atomic nuclei to biological processes. That possibility remains to be tested experimentally. Confirming such a link could open a new avenue for treatment design: fine-tuning how a medicine works by changing its isotopic composition.
While the study does not show that quantum effects are responsible for lithium’s therapeutic action, it identifies a possible mechanism that researchers can now test experimentally.
The researchers hope that future experiments comparing lithium-6 and lithium-7 in systems involving vitamin C could test whether the isotope-dependent effects predicted by the model occur in real chemical or biological systems.
###
Notes to editors
- Dr Marco Sacchi and Amina Mouhamed are available for interview; please contact mediarelations@surrey.ac.uk to arrange.
- The full paper can be found here: https://doi.org/10.1371/journal.pone.0356617
Media Contacts
External Communications and PR team
Phone: +44 (0)1483 684380 / 688914 / 684378
Email: mediarelations@surrey.ac.uk
Out of hours: +44 (0)7773 479911